Dexcom Inc Stock Price Patterns
| DXCM Stock | USD 73.34 0.66 0.89% |
Momentum 57
Buy Extended
Oversold | Overbought |
Quarterly Earnings Growth 1.099 | EPS Estimate Next Quarter 0.6776 | EPS Estimate Current Year 2.0671 | EPS Estimate Next Year 2.4795 | Wall Street Target Price 85.1923 |
Using DexCom hype-based prediction, you can estimate the value of DexCom Inc from the perspective of DexCom response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards DexCom using DexCom's stock options and short interest. It helps to benchmark the overall future attitude of investors towards DexCom using crowd psychology based on the activity and movement of DexCom's stock price.
DexCom Short Interest
An investor who is long DexCom may also wish to track short interest. As short interest increases, investors should be becoming more worried about DexCom and may potentially protect profits, hedge DexCom with its derivative instruments, or be ready for some potential downside.
200 Day MA 74.0914 | Short Percent 0.0509 | Short Ratio 3.13 | Shares Short Prior Month 14.4 M | 50 Day MA 66.6736 |
DexCom Inc Hype to Price Pattern
Investor biases related to DexCom's public news can be used to forecast risks associated with an investment in DexCom. The trend in average sentiment can be used to explain how an investor holding DexCom can time the market purely based on public headlines and social activities around DexCom Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of DexCom's market sentiment to its price can help taders to make decisions based on the overall investors consensus about DexCom.
DexCom Implied Volatility | 0.7 |
DexCom's implied volatility exposes the market's sentiment of DexCom Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if DexCom's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that DexCom stock will not fluctuate a lot when DexCom's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in DexCom to buy its stock at a price that has no basis in reality. In that case, they are not buying DexCom because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
DexCom after-hype prediction price | USD 73.2 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current DexCom contract
Based on the Rule 16, the options market is currently suggesting that DexCom Inc will have an average daily up or down price movement of about 0.0438% per day over the life of the 2026-03-20 option contract. With DexCom trading at USD 73.34, that is roughly USD 0.0321 . If you think that the market is fully incorporating DexCom's daily price movement you should consider acquiring DexCom Inc options at the current volatility level of 0.7%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out DexCom Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of DexCom's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
DexCom After-Hype Price Density Analysis
As far as predicting the price of DexCom at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in DexCom or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of DexCom, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
DexCom Estimiated After-Hype Price Volatility
In the context of predicting DexCom's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on DexCom's historical news coverage. DexCom's after-hype downside and upside margins for the prediction period are 71.25 and 75.15, respectively. We have considered DexCom's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
DexCom is very steady at this time. Analysis and calculation of next after-hype price of DexCom Inc is based on 3 months time horizon.
DexCom Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as DexCom is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading DexCom backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with DexCom, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.34 | 1.95 | 0.14 | 0.56 | 10 Events / Month | 8 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
73.34 | 73.20 | 0.19 |
|
DexCom Hype Timeline
DexCom Inc is currently traded for 73.34. The entity has historical hype elasticity of -0.14, and average elasticity to hype of competition of -0.56. DexCom is forecasted to decline in value after the next headline, with the price expected to drop to 73.2. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.19%, whereas the daily expected return is currently at 0.34%. The volatility of related hype on DexCom is about 117.61%, with the expected price after the next announcement by competition of 72.78. About 98.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 1.03. DexCom Inc had not issued any dividends in recent years. The entity had 4:1 split on the 13th of June 2022. Given the investment horizon of 90 days the next forecasted press release will be in about 10 days. Check out DexCom Basic Forecasting Models to cross-verify your projections.DexCom Related Hype Analysis
Having access to credible news sources related to DexCom's direct competition is more important than ever and may enhance your ability to predict DexCom's future price movements. Getting to know how DexCom's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how DexCom may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| STE | STERIS plc | (0.60) | 10 per month | 1.06 | 0.05 | 1.91 | (1.83) | 10.91 | |
| PODD | Insulet | (4.04) | 11 per month | 0.00 | (0.17) | 3.24 | (3.62) | 13.53 | |
| ZBH | Zimmer Biomet Holdings | (0.55) | 8 per month | 0.00 | (0.13) | 2.92 | (2.20) | 18.45 | |
| PHG | Koninklijke Philips NV | 0.24 | 9 per month | 1.97 | (0.02) | 2.53 | (2.41) | 8.74 | |
| SNN | Smith Nephew SNATS | (0.12) | 9 per month | 0.00 | (0.08) | 2.40 | (1.94) | 14.66 | |
| LH | Laboratory of | (1.07) | 23 per month | 0.00 | (0.06) | 2.71 | (2.13) | 5.89 | |
| WAT | Waters | (0.92) | 11 per month | 1.05 | 0.01 | 3.35 | (2.03) | 8.38 | |
| BIIB | Biogen Inc | (4.45) | 10 per month | 1.67 | 0.11 | 3.11 | (2.55) | 9.61 | |
| WST | West Pharmaceutical Services | (4.50) | 10 per month | 0.00 | (0.21) | 2.50 | (3.58) | 12.18 | |
| TEVA | Teva Pharma Industries | (0.57) | 9 per month | 0.25 | 0.28 | 3.59 | (1.61) | 23.46 |
DexCom Additional Predictive Modules
Most predictive techniques to examine DexCom price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for DexCom using various technical indicators. When you analyze DexCom charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About DexCom Predictive Indicators
The successful prediction of DexCom stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as DexCom Inc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of DexCom based on analysis of DexCom hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to DexCom's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to DexCom's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 4.82 | 4.62 | 5.31 | 9.61 | Days Of Inventory On Hand | 153.18 | 124.18 | 111.77 | 68.37 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out DexCom Basic Forecasting Models to cross-verify your projections. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Will Health Care Equipment & Supplies sector continue expanding? Could DexCom diversify its offerings? Factors like these will boost the valuation of DexCom. Projected growth potential of DexCom fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every DexCom data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 1.099 | Earnings Share 1.8 | Revenue Per Share | Quarterly Revenue Growth 0.216 | Return On Assets |
Understanding DexCom Inc requires distinguishing between market price and book value, where the latter reflects DexCom's accounting equity. The concept of intrinsic value—what DexCom's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push DexCom's price substantially above or below its fundamental value.
It's important to distinguish between DexCom's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding DexCom should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, DexCom's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.